Anúncio
Anúncio

CRBP

CRBP logo

Corbus Pharmaceuticals Holdings, Inc.

8.41
USD
Patrocinado
+0.36
+4.51%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

8.54

+0.13
+1.57%

Relatórios de Lucros CRBP

Rácio de surpresa positiva

CRBP separação 21 de 40 últimas estimativas.

53%

Próximo Relatório

Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.04M
/
-$1.67
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-12.11%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+114.10%

Corbus Pharmaceuticals Holdings, Inc. earnings per share and revenue

On 12 de nov. de 2025, CRBP reported earnings of -1.90 USD per share (EPS) for Q3 25, missing the estimate of -1.74 USD, resulting in a -9.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.39% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -1.67 USD, with revenue projected to reach 2.04 milhão USD, implying an diminuir of -12.11% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Corbus Pharmaceuticals Holdings, Inc. reported EPS of -$1.90, missing estimates by -9.11%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.39%, changed from $10.42 before the earnings release to $11.19 the day after.
The next earning report is scheduled for 09 de mar. de 2026.
Based on 12 analistas, Corbus Pharmaceuticals Holdings, Inc. is expected to report EPS of -$1.67 and revenue of $2.04M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio